New ointment RSS0393 aims to clear psoriasis and ease itch in major trial
Symptom relief
Not yet recruiting
This phase 3 study tests an ointment called RSS0393 against a placebo in 600 adults with mild-to-moderate plaque psoriasis. The main goal is to see if the ointment improves skin clearing and reduces itching after 8 weeks. Participants must have had psoriasis for at least 6 months…
Phase: PHASE3 • Sponsor: Reistone Biopharma Company Limited • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC